Seguir
Lurdes Zamora
Lurdes Zamora
Coordinadora de la Unitat de Biologia Molecular, Servei Laboratori Hematologia, Institut Català d’Oncologia - Institut Josep Carreras
Dirección de correo verificada de iconcologia.net
Título
Citado por
Citado por
Año
Molecular international prognostic scoring system for myelodysplastic syndromes
E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ...
NEJM evidence 1 (7), EVIDoa2200008, 2022
4012022
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung …
M Taron, Y Ichinose, R Rosell, T Mok, B Massuti, L Zamora, JL Mate, ...
Clinical Cancer Research 11 (16), 5878-5885, 2005
3912005
Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome)
S Beà, A López-Guillermo, M Ribas, X Puig, M Pinyol, A Carrió, L Zamora, ...
The American journal of pathology 161 (3), 957-968, 2002
1372002
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
L Palomo, M Meggendorfer, S Hutter, S Twardziok, V Ademà, I Fuhrmann, ...
Blood, The Journal of the American Society of Hematology 136 (16), 1851-1862, 2020
1292020
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols
J Ribera, M Morgades, L Zamora, P Montesinos, I Gómez‐Seguí, ...
Cancer 121 (21), 3809-3817, 2015
632015
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
JM Ribera, M Morgades, J Ciudad, P Montesinos, J Esteve, E Genescà, ...
Blood, The Journal of the American Society of Hematology 137 (14), 1879-1894, 2021
612021
Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis
F Ramos, C Robledo, FM Izquierdo-García, D Suárez-Vilela, R Benito, ...
Oncotarget 7 (21), 30492, 2016
462016
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
L Palomo, M Ibanez, M Abáigar, I Vazquez, S Alvarez, M Cabezon, ...
British Journal of Haematology 188 (5), 605-622, 2020
442020
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia
E Genescà, M Morgades, P Montesinos, P Barba, C Gil, R Guàrdia, ...
Haematologica 105 (6), e294, 2020
392020
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual …
A Bataller, G Oñate, M Diaz‐Beyá, F Guijarro, A Garrido, S Vives, ...
British Journal of Haematology 191 (1), 52-61, 2020
352020
Response to erythropoietic‐stimulating agents in patients with chronic myelomonocytic leukemia
B Xicoy, U Germing, MJ Jimenez, O Garcia, R Garcia, J Schemenau, ...
European journal of haematology 97 (1), 33-38, 2016
352016
Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies
MSV Ferreira, M Kirschner, I Halfmeyer, N Estrada, B Xicoy, S Isfort, ...
Annals of the New York Academy of Sciences 1466 (1), 93-103, 2020
342020
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
L Palomo, O Garcia, M Arnan, B Xicoy, F Fuster, M Cabezón, R Coll, ...
Oncotarget 7 (35), 57021, 2016
312016
Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia
E Lloveras, I Granada, L Zamora, B Espinet, L Florensa, C Besses, ...
Cancer genetics and cytogenetics 148 (1), 71-76, 2004
302004
Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential …
L Florensa, C Besses, L Zamora, B Bellosillo, B Espinet, S Serrano, ...
Blood 103 (6), 2427-2428, 2004
292004
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
A Bataller, A Garrido, F Guijarro, G Oñate, M Diaz-Beyá, M Arnan, ...
Blood advances 6 (4), 1193-1206, 2022
272022
Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis
L Zamora, B Xicoy, M Cabezón, C Fernandez, S Marcé, P Velez, M Xandri, ...
Leukemia & Lymphoma 56 (10), 2973-2974, 2015
272015
Natural history and cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL
C Bueno, JR Tejedor, R Bashford-Rogers, L Gonzalez-Silva, ...
Blood, The Journal of the American Society of Hematology 134 (11), 900-905, 2019
262019
Copy number profiling of adult relapsed B‐cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms
J Ribera, L Zamora, M Morgades, M Mallo, N Solanes, M Batlle, S Vives, ...
Genes, Chromosomes and Cancer 56 (11), 810-820, 2017
242017
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer …
M Cabezón, R Malinverni, J Bargay, B Xicoy, S Marcé, A Garrido, ...
Clinical epigenetics 13, 1-14, 2021
232021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20